Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut)     Collection: Yearbook_2015     Display Documents



ID: 711866.0, MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut) / Yearbook_2015
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension
Authors:Savai, R.; Al-Tamari, H. M.; Sedding, D.; Kojonazarov, B.; Muecke, C.; Teske, R.; Capecchi, M. R.; Weissmann, N.; Grimminger, F.; Seeger, W.; Schermuly, R. T.; Pullamsetti, S. S.
Date of Publication (YYYY-MM-DD):2014-11
Title of Journal:Nat Med
Volume:20
Issue / Number:11
Start Page:1289
End Page:1300
Audience:Not Specified
Abstract / Description:Pulmonary hypertension (PH) is characterized by increased proliferation and apoptosis resistance of pulmonary artery smooth muscle cells (PASMCs). Forkhead box O (FoxO) transcription factors are key regulators of cellular proliferation. Here we show that in pulmonary vessels and PASMCs of human and experimental PH lungs, FoxO1 expression is downregulated and FoxO1 is inactivated via phosphorylation and nuclear exclusion. These findings could be reproduced using ex vivo exposure of PASMCs to growth factors and inflammatory cytokines. Pharmacological inhibition and genetic ablation of FoxO1 in smooth muscle cells reproduced PH features in vitro and in vivo. Either pharmacological reconstitution of FoxO1 activity using intravenous or inhaled paclitaxel, or reconstitution of the transcriptional activity of FoxO1 by gene therapy, restored the physiologically quiescent PASMC phenotype in vitro, linked to changes in cell cycle control and bone morphogenic protein receptor type 2 (BMPR2) signaling, and reversed vascular remodeling and right-heart hypertrophy in vivo. Thus, PASMC FoxO1 is a critical integrator of multiple signaling pathways driving PH, and reconstitution of FoxO1 activity offers a potential therapeutic option for PH.
Free Keywords:Adult; Animals; Apoptosis/drug effects/genetics; Bone Morphogenetic Proteins/metabolism; Bromodeoxyuridine/metabolism; Cell Proliferation/drug effects; Cytokines/metabolism; Female; Forkhead Transcription Factors/genetics/*metabolism; Gene Deletion; Gene Expression Regulation/drug effects; Humans; Hypertension, Pulmonary/genetics/*metabolism/*pathology/physiopathology; Intercellular Signaling Peptides and Proteins/metabolism; Lung/blood supply/pathology/physiopathology; Male; Mice; Muscle, Smooth, Vascular/drug effects/metabolism/pathology; Paclitaxel/pharmacology; Pulmonary Artery/pathology; Quinolones/pharmacology; RNA, Messenger/genetics/metabolism; Rats; *Signal Transduction/drug effects/genetics; Small Molecule Libraries/pharmacology; Vascular Remodeling/drug effects/genetics
External Publication Status:published
Document Type:Article
Communicated by:MPI für Herz- und Lungenforschung
Affiliations:MPI für physiologische und klinische Forschung
External Affiliations:Max-Planck-Institute for Heart and Lung Research, Department of Lung Development and Remodeling, member of the German Center for Lung Research (DZL), Bad Nauheim, Germany. 1] Department of Molecular Cardiology, University Clinic of Giessen and Marburg, Giessen, Germany. [2] Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany. Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC), member of the DZL, Justus-Liebig University, Giessen, Germany. Department of Molecular Cardiology, University Clinic of Giessen and Marburg, Giessen, Germany. Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah, USA. %^ 1435822045
Identifiers:ISSN:1546-170X (Electronic) 1078-8956 (Linking) %R 10.1038/nm.3695
URL:http://www.ncbi.nlm.nih.gov/pubmed/25344740
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.